F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Glucagon-like peptide-1 receptor agonists

Page 1 of 1 ( 19 items )
<<
1
>>

1	Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future directions 9/4/2025 7:48:03 AM \| Browse: 363 \| Download: 21
2	Impact of glucagon-like peptide-1 receptor agonists on the incidence of atrial fibrillation 7/22/2025 8:44:58 AM \| Browse: 12 \| Download: 69
3	GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis 11/29/2024 8:40:08 AM \| Browse: 65 \| Download: 307
4	Glucagon-like peptide-1 agonists: Role of the gut in hypoglycemia unawareness, and the rationale in type 1 diabetes 10/16/2024 10:38:58 AM \| Browse: 90 \| Download: 327
5	Glucagon-like peptide-1 receptor agonists: Exploring the mechanisms from glycemic control to treatment of multisystemic diseases 9/20/2024 8:50:41 AM \| Browse: 60 \| Download: 334
6	Effect of glucagon-like peptide-1 receptor agonists on glucose excursion and inflammation in overweight or obese type 2 diabetic patients 8/11/2023 11:04:23 AM \| Browse: 204 \| Download: 973
7	Semaglutide-eye-catching results 4/12/2023 11:34:59 AM \| Browse: 265 \| Download: 815
8	Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum? 7/5/2022 1:22:29 AM \| Browse: 415 \| Download: 952
9	Acute esophageal necrosis as a complication of diabetic ketoacidosis: A case report 10/29/2021 12:16:54 PM \| Browse: 501 \| Download: 940
10	Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis 9/7/2021 8:15:21 AM \| Browse: 637 \| Download: 1524
11	Clinical effects of antidiabetic drugs on psoriasis: The perspective of evidence-based medicine 8/9/2021 10:25:22 AM \| Browse: 544 \| Download: 1277
12	Recent advances in new-onset diabetes mellitus after kidney transplantation 5/6/2021 11:18:51 AM \| Browse: 593 \| Download: 1374
13	Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy? 9/11/2020 7:11:20 AM \| Browse: 691 \| Download: 1329
14	Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update 8/25/2020 9:16:00 AM \| Browse: 771 \| Download: 1656
15	Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle? 11/27/2018 1:56:41 PM \| Browse: 1031 \| Download: 1679
16	Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome 10/11/2016 11:41:00 AM \| Browse: 1291 \| Download: 1534
17	Incretin-based therapies in prediabetes: Current evidence and future perspectives 12/13/2014 7:02:00 PM \| Browse: 1360 \| Download: 2045
18	Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation 10/29/2014 7:34:00 PM \| Browse: 1151 \| Download: 1696
19	Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes 9/1/2014 12:00:00 PM \| Browse: 1253 \| Download: 1282

Page 1 of 1 ( 19 items )
<<
1
>>

Write to the Help Desk

© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345